> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Depot Buprenorphine Product Development
- URL: https://www.fdaweb.com/guide-on-depot-buprenorphine-product-development/
- Published: 2018-04-23T12:00:00.000Z
- Updated: 2026-09-15T00:00:24.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5141274

*Federal Register* notice: FDA has made available a draft guidance entitled “Opioid Dependence: Developing Depot Buprenorphine Products for Treatment.” The document addresses drug development and trial design issues with studies evaluating depot buprenorphine products (i.e., modified-release products for injection or implantation). To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-04-23/pdf/2018-08361.pdf?ref=fdaweb.com).